For the Inventor, By the Inventor

Enter assignee name

San Carlos, CA, United States of America

Nuvelo, Inc.

USPTO Granted Patents = 39

Forward Citations = 462

Loading Chart...

Loading Chart...

69 inventors (with patents filed for the assignee):

Radoje Drmanac (13 out of 131 patents)

Y Tom Tang (13 out of 92 patents)

Brian Paul Chadwick (8 out of 9 patents)

4. Anna-Maria Frischauf (8 out of 9 patents)

5. George Yeung (7 out of 25 patents)

6. Chenghua Liu (7 out of 17 patents)

7. Bryan J Boyle (6 out of 10 patents)

8. Vincent P Stanton, Jr (5 out of 29 patents)

9. Nancy K Mize (5 out of 11 patents)

10. John E Ford (5 out of 18 patents)

11. Ryle W Goodrich (5 out of 5 patents)

12. Vinod Asundi (4 out of 5 patents)

13. Matthew C Arterburn (4 out of 6 patents)

14. Jian-Rui Wang (3 out of 4 patents)

15. Ivan Labat (3 out of 7 patents)

39 patents: Sort by Forward Citations

1. 8993726 - Antibodies to NTB-A (2015-03-31),

2. 7659054 - Methods for genetic analysis of DNA to detect sequence variances (2010-02-09),

3. 7439327 - Stem cell factor-like proteins and uses thereof (2008-10-21),

4. 7425610 - Methods and materials relating to CD84-like polypeptides and polynucleotides (2008-09-16),

5. 7411052 - Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides (2008-08-12),

6. 7320880 - Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same (2008-01-22),

7. 7319141 - Stem cell growth factor-like polypeptides (2008-01-15),

8. 7122373 - Human genes and gene expression products V (2006-10-17),

9. 7109030 - Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides (2006-09-19),

10. 7067301 - Methods and materials relating to novel prothrombinase-like polypeptides and polynucleotides (2006-06-27),

11. 7029677 - Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells (2006-04-18),

12. 7001731 - Chemokine receptor obtained from a cDNA library of fetal liver-spleen (2006-02-21),

13. 6979548 - Chemokine receptor obtained from a CDNA library of fetal liver-spleen (2005-12-27),

14. 6964868 - Human genes and gene expression products II (2005-11-15),

15. 6919193 - Nucleic acids and polypeptides (2005-07-19),

Nuvelo, Inc. is a biotechnology company specializing in the research and development of novel therapies for the treatment of cardiovascular and autoimmune diseases. With a focus on precision medicine and targeted therapies, Nuvelo aims to improve patient outcomes and quality of life. By leveraging advanced scientific techniques and technologies, the company is committed to discovering innovative solutions and advancing the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

39 Patents

#7 in San Carlos, CA

#2,031 in California

#8,541 in US

#16,945 in the World

San Carlos, CA, United States of America

Nuvelo, Inc.

Forward Citations = 462

69 inventors:

Radoje Drmanac (13 out of 131 patents)

Y Tom Tang (13 out of 92 patents)

Brian Paul Chadwick (8 out of 9 patents)

4. Anna-Maria Frischauf (8 out of 9 patents)

5. George Yeung (7 out of 25 patents)

Please report any incorrect information to support@idiyas.com

Loading…